Valuation: 3billion, Inc.

Market Cap 20TCr 14Cr 12Cr 11Cr 10Cr 19Cr 1.31TCr 20Cr 131.12Cr 51Cr 657.52Cr 52Cr 51Cr 2.18TCr P/E 2025
-107x
P/E 2026 * -
Enterprise Value 18Cr 1L 1L 1L 93.8T 2L 1.2Cr 2L 11.99L 5L 60.1L 5L 5L 1.99Cr EV / Sales 2025
49x
EV / Sales 2026 * -
Free-Float
75.48%
Yield 2025 *
-
Yield 2026 * -
1 day+3.52%
1 week+28.62%
Current month+20.23%
1 month-2.83%
3 months-52.93%
6 months-55.57%
Current year-66.10%
1 week 4,720
Extreme 4720
6,240
1 month 4,260
Extreme 4260
6,320
Current year 4,260
Extreme 4260
18,690
1 year 4,260
Extreme 4260
20,100
3 years 3,025
Extreme 3025
20,100
5 years 3,025
Extreme 3025
20,100
10 years 3,025
Extreme 3025
20,100
Manager TitleAgeSince
Chief Executive Officer 45 10/10/2016
Director of Finance/CFO 46 01/10/2020
Chief Tech/Sci/R&D Officer 46 01/08/2018
Director TitleAgeSince
Director/Board Member 45 10/10/2016
Director/Board Member 44 10/10/2016
Director/Board Member 44 18/11/2020
Date Insider Type Main position Quantity % Market Cap.
16/04/25 Others

Chief Financial Officer

44,000 0.1387%
07/03/25 Fiscal year

Chief Financial Officer

40,000 0.1262%
07/03/25 Fiscal year 10,000 0.0316%
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+28.62%-6.93% - 14Cr
+0.20%+9.04%+122.62%+260.18% 392.61Cr
-0.56%-17.16%+84.53%+80.63% 371Cr
-3.38%+28.49%+254.09%+309.91% 235.39Cr
+1.15%+5.65%-26.06%-34.64% 224.24Cr
-0.46%-4.82%+57.82%-40.06% 193.78Cr
-0.31%-2.73%+173.93%-44.26% 95Cr
+0.36%+10.22%-4.59%+10.87% 90Cr
-0.73%+1.89%-39.05%-11.75% 51Cr
+0.24%+22.59%+1.82% - 51Cr
Average +0.00%+8.83%+61.82%+66.36% 171.73Cr
Weighted average by Cap. -0.42%+4.02%+92.41%+112.35%

Financials

2025 2026 *
Net sales 1.08TCr 75.89L 65.73L 61.27L 56.36L 1.06Cr 72Cr 1.08Cr 7.2Cr 2.83Cr 36Cr 2.85Cr 2.79Cr 119.59Cr -
Net income -580Cr -40.76L -35.3L -32.91L -30.27L -57.14L -39Cr -57.78L -3.87Cr -1.52Cr -19Cr -1.53Cr -1.5Cr -64Cr -
Net Debt -1.69TCr -1.19Cr -1.03Cr -95.88L -88.19L -1.66Cr -112.93Cr -1.68Cr -11Cr -4.42Cr -57Cr -4.46Cr -4.36Cr -187.13Cr -
Logo 3billion, Inc.
3Billion Inc is a Korea-based company principally engaged in the provision of genetic testing services. The Company is principally engaged in the provision of rare genetic disease diagnostic testing services. The Company is also engaged in the research and development of technology that automatically reads the pathogenicity of numerous genetic variants found in the genome.
Employees
-
Date Price Change Volume
05/26/05 ₩6,180.00 +3.52% 1,36,245
04/26/04 ₩5,970.00 +14.37% 2,49,462
03/26/03 ₩5,220.00 +1.56% 91,050
31/26/31 ₩5,140.00 +11.98% 1,04,540
30/26/30 ₩4,590.00 -4.47% 1,66,380

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A394800 Stock